From Wikipedia, the free encyclopedia
|Chemical and physical data|
|Molar mass||145.6 kg/mol|
|(what is this?)|
Intetumumab is a human monoclonal antibody that was being studied for the treatment of solid tumors.
Intetumumab was developed by Centocor, Inc.
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Intetumumab" (PDF). American Medical Association.
- "Intetumumab". AdisInsight. Retrieved 30 January 2017.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|